Zhuang, Richard Z. http://orcid.org/0000-0002-3959-5094
Lock, Roberta
Liu, Bohao http://orcid.org/0000-0001-9107-8839
Vunjak-Novakovic, Gordana http://orcid.org/0000-0002-9382-1574
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (F30HL145921, UH3EB025765, R01 HL076485)
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (P41EB027062)
Center for Hierarchical Manufacturing, National Science Foundation (VUNJAK20G0)
New York State Department of Health - Wadsworth Center (C32606GG)
National Aeronautics and Space Administration (NNX16AO69A)
Article History
Received: 13 May 2021
Accepted: 8 March 2022
First Online: 27 April 2022
Competing interests
: G.V.-N. co-founded TARA Biosystems, a company that has licensed some of the cardiac tissue-engineering methodologies developed in her laboratory, holds equity in the company and is serving on the Board of Directors. The other authors declare no competing interests.